mimmunМедицинская иммунологияMedical Immunology (Russia)1563-06252313-741XSPb RAACI10.15789/1563-0625-2010-1-2-20-40mimmun-38Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESНАТУРАЛЬНЫЕ КИЛЛЕРЫ Т-КЛЕТКИ ЛЕЙКОЦИТАРНЫХ ИНФИЛЬТРАТОВ ПЕЧЕНИ БОЛЬНЫХ С ОПУХОЛЕВЫМ ПРОЦЕССОМ И ВИРУСНЫМ ГЕПАТИТОМNATURAL KILLER T CELLS IN HEPATIC LEUCOCYTE INFILTRATES IN PATIENTS WITH MALIGNANT PROCESS AND VIRAL HEPATITISЛебединскаяО. В.LebedinskayaO. V.lebedinska@mail.ruКабановскаяИ. Н.KabanovskajaI. N.lebedinska@mail.ruАхматоваН. К.AkhmatovaN. K.lebedinska@mail.ruЛебединскаяЕ. А.LebedinskayaE. A.lebedinska@mail.ruЛазареваА. В.LazarevaA. V.lebedinska@mail.ruКиселевскийМ. В.KiselevskyM. V.lebedinska@mail.ruГОУ ВПО «Пермская государственная медицинская академия им. академика Е.А. Вагнера МЗ РФ», г. ПермьRussian FederationГУ «Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН», МоскваRussian FederationГОУ ВПО «Московская государственная медицинская академия им. И.М. Сеченова», МоскваRussian FederationГУ «Российский онкологический научный центр им. Н.Н. Блохина», МоскваRussian Federation201008072014121-22040Copyright © Лебединская О.В., Кабановская И.Н., Ахматова Н.К., Лебединская Е.А., Лазарева А.В., Киселевский М.В., 20142014Лебединская О.В., Кабановская И.Н., Ахматова Н.К., Лебединская Е.А., Лазарева А.В., Киселевский М.В.Lebedinskaya O.V., Kabanovskaja I.N., Akhmatova N.K., Lebedinskaya E.A., Lazareva A.V., Kiselevsky M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.mimmun.ru/mimmun/article/view/38натуральные киллерынатуральные киллеры Т-клеткипеченьлейкоцитарные инфильтратыопухолевый процессвирусный гепатитnatural killersnatural T-killer cellsliverleicocyte infiltratestumor processviral hepatitisReferencesChang Y.J., Huang J.R., Tsai Y.C., Hung J.T., Wu D., Fujio M., Wong C.H., Yu A.L. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids // Proc. Natl. Acad. Sci. USA. – 2007. – Vol. 104, N 25. – P. 10299-10304.Chang Y.J., Huang J.R., Tsai Y.C., Hung J.T., Wu D., Fujio M., Wong C.H., Yu A.L. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids // Proc. Natl. Acad. Sci. USA. – 2007. – Vol. 104, N 25. – P. 10299-10304.Crowe N.Y., Uldrich A.P., Kyparissoudis K., Hammond K.J., Hayakawa Y., Sidobre S., Keating R., Kronenberg M., Smyth M.J., Godfrey D.I. Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells // J. Immunol. – 2003. – Vol. 171. – P. 4020-4027.Crowe N.Y., Uldrich A.P., Kyparissoudis K., Hammond K.J., Hayakawa Y., Sidobre S., Keating R., Kronenberg M., Smyth M.J., Godfrey D.I. Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells // J. Immunol. – 2003. – Vol. 171. – P. 4020-4027.Dhodapkar M.V., Geller M.D., Chang D.H., Shimizu K., Fujii S., Dhodapkar K.M., Krasovsky J. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma // J. Exp. Med. – 2003. – Vol. 197. – P.1667-1676.Dhodapkar M.V., Geller M.D., Chang D.H., Shimizu K., Fujii S., Dhodapkar K.M., Krasovsky J. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma // J. Exp. Med. – 2003. – Vol. 197. – P.1667-1676.Exley M.A., Koziel M.J. To Be or Not to Be NKT: Natural Killer T Cells in the Liver // Hepatology. – 2004. – Vol. 40, N 5. – P. 1033-1040.Exley M.A., Koziel M.J. To Be or Not to Be NKT: Natural Killer T Cells in the Liver // Hepatology. – 2004. – Vol. 40, N 5. – P. 1033-1040.Exley M.A., He Q., Cheng O., Wang R.J., Cheney C.P., Balk S.P., Koziel M.J. Cutting edge: compartmentalization of Th1-like noninvariant CD1dreactive T cells in hepatitis C virus-infected liver // J. Immunol. – 2002. – Vol. 168. – P. 1519-1523.Exley M.A., He Q., Cheng O., Wang R.J., Cheney C.P., Balk S.P., Koziel M.J. Cutting edge: compartmentalization of Th1-like noninvariant CD1dreactive T cells in hepatitis C virus-infected liver // J. Immunol. – 2002. – Vol. 168. – P. 1519-1523.Fuji N., Ueda Y., Fujiwara H., Toh T., Yoshimura T., Yamagishi H. Antitumor effect of a-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver // Clinical Cancer Research. – 2000. – Vol. 6, N 8. – P. 3380-3387.Fuji N., Ueda Y., Fujiwara H., Toh T., Yoshimura T., Yamagishi H. Antitumor effect of a-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver // Clinical Cancer Research. – 2000. – Vol. 6, N 8. – P. 3380-3387.Fuji S., Shimizu K., Smith C. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein // J. Exp. Med. – 2003. – Vol. 198. – P. 267-279.Fuji S., Shimizu K., Smith C. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein // J. Exp. Med. – 2003. – Vol. 198. – P. 267-279.Godfrey D.I., MacDonald H.R., Kronenberg M.M., Smyth M.J., Van Kaer L. NKT cells: what’s in a name? // Nat. Rev. Immunol. – 2004. – Vol. 4. – P. 231-237.Godfrey D.I., MacDonald H.R., Kronenberg M.M., Smyth M.J., Van Kaer L. NKT cells: what’s in a name? // Nat. Rev. Immunol. – 2004. – Vol. 4. – P. 231-237.Hammond K.J.L., Pelikan S.B., Crowe N.Y., Randle-Barrett E., Nakayama T., Taniguchi M., Smyth M.J., van Driel I.R., Scollay R., Baxter A.G., Godfrey D.I. NKT cells are phenotypically and functionally diverse // Eur. J. Immunol. – 1999. – Vol. 29. – P. 3768-3781.Hammond K.J.L., Pelikan S.B., Crowe N.Y., Randle-Barrett E., Nakayama T., Taniguchi M., Smyth M.J., van Driel I.R., Scollay R., Baxter A.G., Godfrey D.I. NKT cells are phenotypically and functionally diverse // Eur. J. Immunol. – 1999. – Vol. 29. – P. 3768-3781.Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo // J. Exp. Med. – 2000. – Vol. 192, N 7. – P. 921-930.Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo // J. Exp. Med. – 2000. – Vol. 192, N 7. – P. 921-930.Kenna T., Mason L.G., Porcelli S.A., Koezuka Y., Hegarty J.E., O’Farrelly C., Doherty D.G. NKT cells from normal and tumor-bearing human liver are phenotypically and functionally distinct from murine NKT cells // J. Immunol. – 2003. – Vol. 166, N 11. – P. 6578-6584.Kenna T., Mason L.G., Porcelli S.A., Koezuka Y., Hegarty J.E., O’Farrelly C., Doherty D.G. NKT cells from normal and tumor-bearing human liver are phenotypically and functionally distinct from murine NKT cells // J. Immunol. – 2003. – Vol. 166, N 11. – P. 6578-6584.Kenna T., Mason L.G., Porcelli S.A., Koezuka Y., Hegarty J.E., O’Farrelly C., Doherty D.G. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells // J. Immunol. – 2003. – Vol. 171. – P. 1775-1779.Kenna T., Mason L.G., Porcelli S.A., Koezuka Y., Hegarty J.E., O’Farrelly C., Doherty D.G. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells // J. Immunol. – 2003. – Vol. 171. – P. 1775-1779.Kenna T., Golden-Mason L., Porcelli S.A., Koezuka Y., Hegarty J.E., O’Farrelly C., Doherty D.G. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver // Cancer Immunol Immunother. – 2007. – Vol. 56, N 4. – P. 563-72.Kenna T., Golden-Mason L., Porcelli S.A., Koezuka Y., Hegarty J.E., O’Farrelly C., Doherty D.G. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver // Cancer Immunol Immunother. – 2007. – Vol. 56, N 4. – P. 563-72.Kikuchi A., Nieda M., Koezuka Y., Ishihara S., IshikawaY., Tadokoro K., Durrant S., Boyd S., Juji T., Nicol A. In vitro anti-tumour activity of alphagalactosylceramide-stimulated human invariant Valpha24 + NKT cells against melanoma // Br. J. Cancer. – 2001. – Vol. 85. – P. 741-746.Kikuchi A., Nieda M., Koezuka Y., Ishihara S., IshikawaY., Tadokoro K., Durrant S., Boyd S., Juji T., Nicol A. In vitro anti-tumour activity of alphagalactosylceramide-stimulated human invariant Valpha24 + NKT cells against melanoma // Br. J. Cancer. – 2001. – Vol. 85. – P. 741-746.Kitamura H., Iwakabe K., Yahata T., Nishimura S., Ohta A., Ohmi Y., Sato M., Takeda K., Okumura K., Van Kaer L., Kawano T., Taniguchi M., Nishimura T. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells // J. Exp. Med. –1999. – Vol. 189. – P. 1121-1127.Kitamura H., Iwakabe K., Yahata T., Nishimura S., Ohta A., Ohmi Y., Sato M., Takeda K., Okumura K., Van Kaer L., Kawano T., Taniguchi M., Nishimura T. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells // J. Exp. Med. –1999. – Vol. 189. – P. 1121-1127.Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes // Annual review of immunology. – 2005. – Vol. 23. – P. 877-900.Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes // Annual review of immunology. – 2005. – Vol. 23. – P. 877-900.Levy O., Orange J.S., Hibberd P., Steinberg S., LaRussa P., Weinberg A., Wilson S.B., Shaulov A., Fleisher G., Geha R.S., Bonilla F.A., Exley M. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a ovel deficiency in natural killer T cells // J. Infect. Dis. – 2003. – Vol. 188. – P. 948-953.Levy O., Orange J.S., Hibberd P., Steinberg S., LaRussa P., Weinberg A., Wilson S.B., Shaulov A., Fleisher G., Geha R.S., Bonilla F.A., Exley M. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a ovel deficiency in natural killer T cells // J. Infect. Dis. – 2003. – Vol. 188. – P. 948-953.Matsuda J.L., Gapin L., Baron J.L., Sidobre S., Stetson D.B., Mohrs M., Locksley R.M., Kronenberg M. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo // Proc. Natl. Acad. Sci. U. S. A. – 2003. – Vol. 100. – P. 8395-8400.Matsuda J.L., Gapin L., Baron J.L., Sidobre S., Stetson D.B., Mohrs M., Locksley R.M., Kronenberg M. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo // Proc. Natl. Acad. Sci. U. S. A. – 2003. – Vol. 100. – P. 8395-8400.Metelitsa L.S., Naidenko O.V., Kant A., Wu H.W., Loza M.J., Perussia B., Kronenberg M., Seeger R.C. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells // J. Immunol. – 2001. – Vol. 167. – P. 3114-3122.Metelitsa L.S., Naidenko O.V., Kant A., Wu H.W., Loza M.J., Perussia B., Kronenberg M., Seeger R.C. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells // J. Immunol. – 2001. – Vol. 167. – P. 3114-3122.Motohashi S., Kobayashi S., Ito T., Magara K.K., Mikuni O., Kamada N., Iizasa T., Nakayama T., Fujisawa T., Taniguchi M. Preserved IFN-alpha production of circulating V alpha 24 NKT cells in primary lung cancer patients // Int. J. Cancer. – 2002. – Vol. 102. – P. 159-165.Motohashi S., Kobayashi S., Ito T., Magara K.K., Mikuni O., Kamada N., Iizasa T., Nakayama T., Fujisawa T., Taniguchi M. Preserved IFN-alpha production of circulating V alpha 24 NKT cells in primary lung cancer patients // Int. J. Cancer. – 2002. – Vol. 102. – P. 159-165.Pillai A.B., George T.I., Dutt S., Teo P., Strober S. NKT cells can prevent graft-versushost disease and permit graft antitumor activity after bone marrow transplantation. // J. Immunol. – 2007. – Vol. 178, N 10. – P. 6242-51.Pillai A.B., George T.I., Dutt S., Teo P., Strober S. NKT cells can prevent graft-versushost disease and permit graft antitumor activity after bone marrow transplantation. // J. Immunol. – 2007. – Vol. 178, N 10. – P. 6242-51.Poulton L.D., Smyth M.J., Hawke C.G., Silveira P., Shepherd D., Naidenko O.V., Godfrey D.I., Baxter A.G. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice // Int. Immunol. – 2001. – Vol. 13. – P. 887-896.Poulton L.D., Smyth M.J., Hawke C.G., Silveira P., Shepherd D., Naidenko O.V., Godfrey D.I., Baxter A.G. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice // Int. Immunol. – 2001. – Vol. 13. – P. 887-896.Seino K., Motohashi S., Fujisawa T., Nakayama T., Taniguchi M. Natural killer T cellmediated antitumor i mmune responses and their clinical applications // Cancer Sci. – 2006. – Vol. 97, N 9. – P. 807-812.Seino K., Motohashi S., Fujisawa T., Nakayama T., Taniguchi M. Natural killer T cellmediated antitumor i mmune responses and their clinical applications // Cancer Sci. – 2006. – Vol. 97, N 9. – P. 807-812.Smyth M.J., Godfrey D.I. NKT cells and tumor immunity-a double-edged sword // Nat. Immunol. – 2000. – Vol. 1. – P. 459-460.Smyth M.J., Godfrey D.I. NKT cells and tumor immunity-a double-edged sword // Nat. Immunol. – 2000. – Vol. 1. – P. 459-460.Smyth M.J., Crowe N.Y., Takeda K. NKT cells – conductors of tumor immunity? // Curr. Opin. Immunol. – 2002. – Vol. 14. – P. 165-171.Smyth M.J., Crowe N.Y., Takeda K. NKT cells – conductors of tumor immunity? // Curr. Opin. Immunol. – 2002. – Vol. 14. – P. 165-171.Sonoda K.H., Taniguchi M., Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells // J. Immunol. – 2002. – Vol. 168. – P. 2028-2034.Sonoda K.H., Taniguchi M., Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells // J. Immunol. – 2002. – Vol. 168. – P. 2028-2034.Spadaro M., Curcio C., Varadhachary A., Cavallo F., Engelmayer J., Blezinger P., Pericle F., Forni G. Requirement for IFN-gamma, CD8+ T lymphocytes, and NKT cells in talactoferrininduced inhibition of neu + tumors // Cancer Res. – 2007. – Vol. 67, N 13. – P. 6425-32.Spadaro M., Curcio C., Varadhachary A., Cavallo F., Engelmayer J., Blezinger P., Pericle F., Forni G. Requirement for IFN-gamma, CD8+ T lymphocytes, and NKT cells in talactoferrininduced inhibition of neu + tumors // Cancer Res. – 2007. – Vol. 67, N 13. – P. 6425-32.Swann J.B., Coquet J.M., Smyth M.J., Godfrey D.I. CD1-restricted T cells and tumor immunity // Curr. Top. Microbiol. Immunol. –2007. – Vol. 314. – P. 293-323.Swann J.B., Coquet J.M., Smyth M.J., Godfrey D.I. CD1-restricted T cells and tumor immunity // Curr. Top. Microbiol. Immunol. –2007. – Vol. 314. – P. 293-323.Trobonjaca Z., Leith user F., M ller P., Schirmbeck R., Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFNγ release by liver NKT cells // J. Immunol. – 2001. – Vol. 167, N 3. – P. 1413-1422.Trobonjaca Z., Leith user F., M ller P., Schirmbeck R., Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFNγ release by liver NKT cells // J. Immunol. – 2001. – Vol. 167, N 3. – P. 1413-1422.Trobonjaca Z., Kroger A., Stober D., Leith user F., M ller P., Hauser H., Schirmbeck R., Reimann J. Activating immunity in the liver. II. IFNb attenuates NK cell-dependent liver injury triggered by liver NKT cell activation // J. Immunol. – 2002. – Vol. 168, N 8. – P. 3763-3770.Trobonjaca Z., Kroger A., Stober D., Leith user F., M ller P., Hauser H., Schirmbeck R., Reimann J. Activating immunity in the liver. II. IFNb attenuates NK cell-dependent liver injury triggered by liver NKT cell activation // J. Immunol. – 2002. – Vol. 168, N 8. – P. 3763-3770.Wilson S.B., Delovitch T.L. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity // Nat. Rev. Immunol. – 2003. – Vol. 3. – P. 211-222.Wilson S.B., Delovitch T.L. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity // Nat. Rev. Immunol. – 2003. – Vol. 3. – P. 211-222.
The authors declare that there are no conflicts of interest present.